임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

13건 표시

1/2상모집 예정· B-cell Acute Lymphoblastic Leukemia
A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia
협력: 암젠, 화이자
상세 →NCT07313852
1/2상모집 중단 (진행 중)· Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia
리드: 암젠
상세 →NCT07134088
1/2상모집 중· Glioma
Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors
협력: 암젠
상세 →NCT07243470
1/2상모집 중· Melanoma
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
협력: 암젠
상세 →NCT06814496
1/2상모집 중· Thyroid Eye Disease
A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease
리드: 암젠
상세 →NCT06401044
1/2상모집 중· Lymphoblastic Leukemia
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
협력: 암젠
상세 →NCT05848687
1/2상모집 중단 (진행 중)· Gastric Cancer
A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.
리드: 암젠
상세 →NCT05322577
1/2상모집 중단 (진행 중)· Non Small Cell Lung Cancer
Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients
협력: 암젠
상세 →NCT05074810
1/2상모집 중단 (진행 중)· Advanced MTAP-null Solid Tumors
A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)
리드: 암젠
상세 →NCT05094336
1/2상모집 중단 (진행 중)· Multiple Myeloma
Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma
협력: 암젠, GSK
상세 →NCT04822337
1/2상모집 중단 (진행 중)· B Cell Precursor Acute Lymphoblastic Leukemia
A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL
리드: 암젠
상세 →NCT04521231
1/2상모집 중단 (진행 중)· Soft Tissue Sarcoma
TVEC and Preop Radiation for Sarcoma (8 ml Dose)
협력: 암젠
상세 →NCT04599062
1/2상모집 중단 (진행 중)· Acute Lymphoblastic Leukemia
A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance
협력: 암젠
상세 →NCT03114865

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.